RAPT Therapeutics (RAPT) Accounts Payables: 2020-2024
Historic Accounts Payables for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $1.4 million.
- Therapeutics' Accounts Payables fell 73.95% to $1.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $1.4 million, marking a year-over-year decrease of 73.95%. This contributed to the annual value of $5.2 million for FY2023, which is 53.82% up from last year.
- According to the latest figures from Q3 2024, Therapeutics' Accounts Payables is $1.4 million, which was down 49.19% from $2.7 million recorded in Q2 2024.
- Therapeutics' 5-year Accounts Payables high stood at $8.9 million for Q1 2023, and its period low was $1.4 million during Q3 2024.
- For the 3-year period, Therapeutics' Accounts Payables averaged around $4.2 million, with its median value being $4.0 million (2022).
- In the last 5 years, Therapeutics' Accounts Payables skyrocketed by 361.83% in 2023 and then plummeted by 73.95% in 2024.
- Therapeutics' Accounts Payables (Quarterly) stood at $2.4 million in 2020, then fell by 16.11% to $2.0 million in 2021, then spiked by 68.33% to $3.4 million in 2022, then skyrocketed by 53.82% to $5.2 million in 2023, then plummeted by 73.95% to $1.4 million in 2024.
- Its last three reported values are $1.4 million in Q3 2024, $2.7 million for Q2 2024, and $6.8 million during Q1 2024.